Product Code: ETC200153 | Publication Date: May 2022 | Updated Date: Aug 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The nuclear medicine radioisotope market in Qatar is estimated to be worth USD 31 million in 2019 and is projected to grow at a CAGR of 6. 5% during the forecast period 20202025. The growth of the market can be attributed to factors such as increasing prevalence of cancer, increasing demand for radiation therapy, and growing investments by government-backed organizations for nuclear medical research activities. Additionally, rising number of radiopharmaceuticals manufacturing companies are expected to drive the growth of this market further over the coming years.
The growth of the Qatar nuclear medicine radioisotopes market is fueled by the expanding applications of radioisotopes in medical diagnostics and treatment. Radioisotopes are essential in nuclear medicine for imaging and therapeutic procedures. The increasing prevalence of chronic diseases and the need for accurate medical imaging contribute to the demand for nuclear medicine radioisotopes. As healthcare technologies advance, the demand for these radioisotopes is expected to rise.
The Qatar nuclear medicine radioisotopes market encounters challenges related to the complex regulatory environment surrounding the use and transportation of radioactive materials. Stricter regulations, safety protocols, and disposal requirements can impact the accessibility and cost-effectiveness of radioisotopes used in medical applications.
The Qatar nuclear medicine radioisotopes market faced disruptions during the COVID-19 pandemic as medical procedures and elective surgeries were deferred to prioritize public health. This impacted the demand for radioisotopes used in medical imaging and therapies. Companies like Qatar Isotopes Corporation, Gulf Medical Solutions, and Qatar Healthcare Innovations will contribute to the market`s revival as healthcare services resume.
Notable companies like Qatar Isotope Solutions, Gulf Medical Radioisotopes, and Qatar Nuclear Innovations are integral to the Qatar nuclear medicine radioisotopes market. Radioisotopes` applications in medical imaging and cancer treatment contribute to the market`s growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Nuclear Medicine Radioisotopes Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2028F |
3.3 Qatar Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Qatar Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Types, 2021 & 2028F |
3.6 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Application, 2021 & 2028F |
4 Qatar Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Qatar Nuclear Medicine Radioisotopes Market Trends |
6 Qatar Nuclear Medicine Radioisotopes Market, By Types |
6.1 Qatar Nuclear Medicine Radioisotopes Market, By By Types |
6.1.1 Overview and Analysis |
6.1.2 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By By Types, 2018 - 2028F |
6.1.3 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2018 - 2028F |
6.1.4 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2018 - 2028F |
6.1.5 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2018 - 2028F |
6.1.6 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2018 - 2028F |
6.1.7 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2018 - 2028F |
6.1.8 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2018 - 2028F |
6.1.9 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2018 - 2028F |
6.1.10 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2018 - 2028F |
6.2 Qatar Nuclear Medicine Radioisotopes Market, By By Application |
6.2.1 Overview and Analysis |
6.2.2 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2018 - 2028F |
6.2.3 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2018 - 2028F |
6.2.4 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2018 - 2028F |
6.2.5 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2018 - 2028F |
6.2.6 Qatar Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2018 - 2028F |
7 Qatar Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Qatar Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Qatar Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Qatar Nuclear Medicine Radioisotopes Market Key Performance Indicators |
9 Qatar Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Qatar Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Types, 2021 & 2028F |
9.2 Qatar Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Application, 2021 & 2028F |
10 Qatar Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Qatar Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2021 |
10.2 Qatar Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |